[The kidney, its anatomy and main functions].
Levassort H, Essig M.
Soins Gerontol. 2024 Jan-Feb;29(165):10-20. doi: 10.1016/j.sger.2023.12.003. Epub 2024 Jan 18.
SGLT2 Inhibitors and Kidney Protection: Mechanisms Beyond Tubuloglomerular Feedback.
Upadhyay A.
Kidney360. 2024 May 1;5(5):771-782. doi: 10.34067/KID.0000000000000425. Epub 2024 Mar 25.
Flow-enhanced vascularization and maturation of kidney organoids in vitro.
Homan KA, Gupta N, Kroll KT, Kolesky DB, Skylar-Scott M, Miyoshi T, Mau D, Valerius MT, Ferrante T, Bonventre JV, Lewis JA, Morizane R.
Nat Methods. 2019 Mar;16(3):255-262. doi: 10.1038/s41592-019-0325-y. Epub 2019 Feb 11.
Lactate metabolism and lactylation in kidney diseases: insights into mechanisms and therapeutic opportunities.
Cheng Y, Guo L.
Ren Fail. 2025 Dec;47(1):2469746. doi: 10.1080/0886022X.2025.2469746. Epub 2025 Feb 26.
Endothelial dysfunction in the aging kidney.
Borri M, Jacobs ME, Carmeliet P, Rabelink TJ, Dumas SJ.
Am J Physiol Renal Physiol. 2025 Apr 1;328(4):F542-F562. doi: 10.1152/ajprenal.00287.2024. Epub 2025 Feb 11.
Autoantibody-triggered podocyte membrane budding drives autoimmune kidney disease.
Lahme K, Sachs W, Froembling S, Loreth D, Böttcher-Dierks V, Neumann K, Hann FM, Arkan N, Brehler M, Reichelt J, Sgries A, Surmann K, Gaffling S, Adler MR, Sáez PJ, Wedekind U, Lampert A, Tasika E, Saftig P, Conze C, Thünauer R, Skuza S, Neitzel K, Zielinski S, Brand J, Bonn S, Michalik S, Völker U, Zimmermann M, Wiech T, Meyer TN, Fester L, Meyer-Schwesinger C.
Cell. 2026 Jan 8;189(1):123-142.e30. doi: 10.1016/j.cell.2025.11.010. Epub 2025 Dec 4.
Comparative single-cell analyses identify shared and divergent features of human and mouse kidney development.
Kim S, Koppitch K, Parvez RK, Guo J, Achieng M, Schnell J, Lindström NO, McMahon AP.
Dev Cell. 2024 Nov 4;59(21):2912-2930.e7. doi: 10.1016/j.devcel.2024.07.013. Epub 2024 Aug 8.
State-of-the-Art-Review: Mechanisms of Action of SGLT2 Inhibitors and Clinical Implications.
Vallon V.
Am J Hypertens. 2024 Oct 14;37(11):841-852. doi: 10.1093/ajh/hpae092.
Pathophysiology and management of hypokalemia: a clinical perspective.
Unwin RJ, Luft FC, Shirley DG.
Nat Rev Nephrol. 2011 Feb;7(2):75-84. doi: 10.1038/nrneph.2010.175.
Kidney-specific WNK1 amplifies kidney tubule responsiveness to potassium via WNK body condensates.
Boyd-Shiwarski CR, Beacham RT, Lashway JA, Querry KE, Griffiths SE, Shiwarski DJ, Knoell SA, Nguyen NH, Nkashama LJ, Valladares MN, Bandaru A, Marciszyn AL, Franks J, Sullivan M, Watkins SC, Rodan AR, Huang CL, Stocker SD, Kashlan OB, Subramanya AR.
J Clin Invest. 2025 Jun 10;135(15):e188792. doi: 10.1172/JCI188792. eCollection 2025 Aug 1.
